56% increase in global patent publications over the last five years signals growing interest in the cardiac monitoring market which is expected to grow to $3 billion per year by 2029 according to ...

The HeartBeam System is a portable non-invasive recorder intended to record, store, and transfer a patient's 3-Lead (in three-directions) electrocardiogram ("ECG") acquired from 5 electrodes. The ...

AliveCor has secured a new 510(k) clearance from the FDA for its handheld, six-lead electrocardiogram device, unlocking the rapid detection of potentially dangerous cardiovascular side effects that ...

The electrocardiogram (ECG) is used to diagnose and monitor a multitude of conditions affecting the heart. More than just a measure of pulse rate, the ECG reveals the complex electrical activity of ...

In the United States, heart disease is the most common chronic disease and remains the leading cause of death for both men and women, making the ability to provide accurate continuous cardiac ...

Data from AliveCor’s KardiaMobile 6L ECG, a portable ECG device that can detect AFib and other heart rhythm conditions, is viewable on a smart phone and sent to GE Healthcare’s MUSE cardiac management ...

The FDA has cleared GE Healthcare's ECG solution, called the portable MAC 800, which the company says is based on cell phone technology. The device was originally introduced into China's market last ...

LONDON--(BUSINESS WIRE)--The global electrocardiography devices (ECG) market is expected to post a CAGR of over 6% during the period 2019-2023, according to the latest market research report by ...

The company was ranked second worldwide out of 243 companies evaluated in 12-lead ECG innovation in PatentVest's“Total Cardiac Intelligence” report. HeartBeam's ranking underscores the rapid ...

HeartBeam (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions for remote cardiac care, has been recognized as a Global IP and Technology Leader in Portable ...